Actionable news
All posts from Actionable news
Actionable news in DYAX: Dyax Corp.,

Dyax (DYAX) Highlighted As Today's Perilous Reversal Stock

Trade-Ideas LLC identified Dyax ( DYAX) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Dyax as such a stock due to the following factors:

  • DYAX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $39.1 million.
  • DYAX has traded 85,513 shares today.
  • DYAX is down 3.5% today.
  • DYAX was up 6.1% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in DYAX with the Ticky from Trade-Ideas. See the FREE profile for DYAX NOW at Trade-Ideas More details on DYAX: Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. It offers KALBITOR for the treatment of acute attacks of HAE. Currently there are 6 analysts that rate Dyax a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for Dyax has been...